Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers
Author:
Publisher
Elsevier BV
Subject
Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology
Reference78 articles.
1. Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: a synergistic combination nanotherapy for ovarian cancer treatment;Cai;Biomaterials,2015
2. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors;Can Sarisozen;Eur. J. Pharm. Biopharm.,2014
3. Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics;Grinberg;Acta Biomater.,2009
4. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front. Pharmacol.,2017
5. Advances in antibody-drug conjugates: a new era of targeted cancer therapy;Sau;Drug Discov. Today,2017
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23
2. Endophytic fungi: A future prospect for breast cancer therapeutics and drug development;Heliyon;2024-07
3. Current development of theragnostic nanoparticles for women’s cancer treatment;Biomedical Materials;2024-05-08
4. The impact of gold nanoparticles conjugated with albumin on prostate and breast cancer cell lines: insights into cytotoxicity, cellular uptake, migration, and adhesion potential;Journal of Nanoparticle Research;2024-05
5. Co‐encapsulation of Curcumin and Paclitaxel using Non‐ionic Surfactant Based Nanovesicles Suppresses Growth of Ovarian Carcinoma through the Inhibition of Nuclear Factor κB and AKT1;ChemistrySelect;2024-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3